4th Quarter - Report
WINNING STRATEGIES WASHINGTON for NOVARTIS
Client
Income
$40,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Protection and Innovative Biologic Medicines Act of 2009 Implementation of health care reform Implementation and progress of the deficit reduction committee
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Budget/Appropriations BUD
FY12 Department of Defense Appropriations Orphan drugs and tax issues PDUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALEX DELPIZZO | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.